Arixtra and Pancreatitis aggravated - a phase IV clinical study of FDA data

Summary:

Pancreatitis aggravated is reported as a side effect among people who take Arixtra (fondaparinux sodium), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Levaquin, and have Hiv infection.

The phase IV clinical study analyzes which people have Pancreatitis aggravated when taking Arixtra. It is created by eHealthMe based on reports of 9,755 people who have side effects when taking Arixtra from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Pancreatitis aggravated?

Pancreatitis aggravated (serious inflammation of pancreas) is found to be associated with 1,465 drugs and 528 conditions by eHealthMe. Check the latest studies of Pancreatitis aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

9,755 people reported to have side effects when taking Arixtra.
Among them, 12 people (0.12%) have Pancreatitis aggravated.

Could Arixtra cause Pancreatitis aggravated?

Among these 12 people:

How long have people been on Arixtra when they have Pancreatitis aggravated? *

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pancreatitis aggravated when taking Arixtra? *

  • female: 44.44 %
  • male: 55.56 %

What is the age of people who have Pancreatitis aggravated when taking Arixtra? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.11 %
  • 40-49: 22.22 %
  • 50-59: 44.44 %
  • 60+: 22.22 %

What are other drugs people take besides Arixtra? *

  1. Ziagen: 5 people, 41.67%
  2. Tamsulosin: 5 people, 41.67%
  3. Hydrocodone Bitartrate And Acetaminophen: 5 people, 41.67%
  4. Heparin: 5 people, 41.67%
  5. Vitamin D2: 5 people, 41.67%
  6. Pazeo: 5 people, 41.67%
  7. Benicar: 5 people, 41.67%
  8. Klor-Con: 5 people, 41.67%
  9. Symtuza: 5 people, 41.67%
  10. Levaquin: 5 people, 41.67%

What are other side effects people have besides Pancreatitis aggravated? *

  1. Dehydration (dryness resulting from the removal of water): 6 people, 50.00%
  2. Acute Kidney Failure: 5 people, 41.67%
  3. Pain: 5 people, 41.67%
  4. Nausea And Vomiting: 5 people, 41.67%
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable): 5 people, 41.67%
  6. Diarrhea: 5 people, 41.67%
  7. Stress And Anxiety: 5 people, 41.67%
  8. Emotional Distress: 5 people, 41.67%
  9. Fanconi Syndrome Acquired (self developed genetic disease of kidney damage due to defective transport system): 4 people, 33.33%
  10. Nausea (feeling of having an urge to vomit): 4 people, 33.33%

What are the existing conditions these people have? *

  1. Hiv Infection: 5 people, 41.67%
  2. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 16.67%
  3. Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 16.67%
  4. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 16.67%
  5. Adrenocortical Carcinoma (adrenal cortex cancer): 2 people, 16.67%
  6. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 2 people, 16.67%
  7. Non-Small Cell Lung Cancer Stage Iv: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and have Pancreatitis aggravated?

- Check whether Pancreatitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arixtra:

Pancreatitis aggravated treatments and more:

How severe was Pancreatitis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of fondaparinux sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arixtra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis aggravated:

Browse all the conditions that are associated with Pancreatitis aggravated:


How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium (the active ingredients of Arixtra) and Arixtra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: